213 related articles for article (PubMed ID: 29348196)
21. Hydrocortisone for Preventing Mortality and Bronchopulmonary Dysplasia in Preterm Infants with or without Chorioamnionitis Exposure: A Meta-Analysis of Randomized Trials.
Zhou J; Yu Z; Chen C
Am J Perinatol; 2021 Jun; 38(7):662-668. PubMed ID: 31899929
[TBL] [Abstract][Full Text] [Related]
22. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
23. Early low-dose hydrocortisone: is the neurodevelopment affected?
Ofman G; Perez M; Farrow KN
J Perinatol; 2018 Jun; 38(6):636-638. PubMed ID: 29467523
[TBL] [Abstract][Full Text] [Related]
24. Chronic Inflammatory Placental Lesions Correlate With Bronchopulmonary Dysplasia Severity in Extremely Preterm Infants.
Sharma A; Sood BG; Qureshi F; Xin Y; Jacques SM
Pediatr Dev Pathol; 2021; 24(5):430-437. PubMed ID: 34048316
[TBL] [Abstract][Full Text] [Related]
25. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.
Watterberg KL; Gerdes JS; Cole CH; Aucott SW; Thilo EH; Mammel MC; Couser RJ; Garland JS; Rozycki HJ; Leach CL; Backstrom C; Shaffer ML
Pediatrics; 2004 Dec; 114(6):1649-57. PubMed ID: 15574629
[TBL] [Abstract][Full Text] [Related]
27. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.
He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X
Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333
[TBL] [Abstract][Full Text] [Related]
28. Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension.
Mestan KK; Check J; Minturn L; Yallapragada S; Farrow KN; Liu X; Su E; Porta N; Gotteiner N; Ernst LM
Placenta; 2014 Aug; 35(8):570-4. PubMed ID: 24906549
[TBL] [Abstract][Full Text] [Related]
29. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
30. Placental Complications and Bronchopulmonary Dysplasia: EPIPAGE-2 Cohort Study.
Torchin H; Ancel PY; Goffinet F; Hascoët JM; Truffert P; Tran D; Lebeaux C; Jarreau PH
Pediatrics; 2016 Mar; 137(3):e20152163. PubMed ID: 26908662
[TBL] [Abstract][Full Text] [Related]
31. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM
J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
33. Placental Villous Vascularity Is Decreased in Premature Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Yallapragada SG; Mestan KK; Palac H; Porta N; Gotteiner N; Hamvas A; Grobman W; Ernst LM
Pediatr Dev Pathol; 2016; 19(2):101-7. PubMed ID: 26366786
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D and bronchopulmonary dysplasia in preterm infants.
Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H
J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562
[TBL] [Abstract][Full Text] [Related]
35. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
36. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
[TBL] [Abstract][Full Text] [Related]
37. Effect of chorioamnionitis on mortality, early onset neonatal sepsis and bronchopulmonary dysplasia in preterm neonates with birth weight of < 1,500 grams.
Stimac M; Juretić E; Vukelić V; Matasić NP; Kos M; Babić D
Coll Antropol; 2014 Mar; 38(1):167-71. PubMed ID: 24851613
[TBL] [Abstract][Full Text] [Related]
38. Survival without Bronchopulmonary Dysplasia of Extremely Preterm Infants: A Predictive Model at Birth.
Baud O; Laughon M; Lehert P
Neonatology; 2021; 118(4):385-393. PubMed ID: 34004607
[TBL] [Abstract][Full Text] [Related]
39. Effects of postnatal hydrocortisone on cytokine profile in extremely preterm infants.
Tamura K; Nagaoka M; Inomata S; Kawasaki Y; Makimoto M; Yoshida T
Pediatr Int; 2022 Jan; 64(1):e15205. PubMed ID: 35831259
[TBL] [Abstract][Full Text] [Related]
40. Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia.
Eriksson L; Haglund B; Odlind V; Altman M; Kieler H
Pediatr Pulmonol; 2014 Jul; 49(7):665-72. PubMed ID: 24039136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
